Association between metabolic syndrome and risk of stroke: A meta-analysis of cohort studies

Cerebrovascular Diseases

Volumn 25, Issue 6, 2008, Pages 539-547

  Li, Wei ^a,b   Ma, Dongrui ^b   Liu, Ming ^a   Liu, Hua ^a   Feng, Shejun ^a   Hao, Zilong ^a   Wu, Bo ^a   Zhang, Shihong ^a  

^a SICHUAN UNIVERSITY   (China)

^b YAN'AN UNIVERSITY   (China)

Author keywords

Meta analysis; Metabolic syndrome; Stroke

Indexed keywords

ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; HUMAN; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; STROKE;

DATA COLLECTION; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; PREVALENCE; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK FACTORS; STROKE;

EID: 45549087871     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000131672     Document Type: Article

References (26)

1. Procopiou M, Philippe J: The Metabolic syndrome and type 2 diabetes: epidemiological figures and country specificities. Cerebrovasc Dis 2005;20(suppl 1):2-8.
2. Kaplan NM: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-1520.
3. Reaven GM: Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
4. WHO: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. 1. Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999 (WHO/NCD/NCS99.2).
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
6. Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005;28:2745-2749.
7. Ford ES, Giles WH: Mokdad AH: Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004;27:2444-2449.
8. Koren-Morag N, Goldbourt U, Tanne D: Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke 2005;36:1366-1371.
9. Najarian RM, Sullivan LM, Kannel WB, Wilson PWF, D'Agostino RB, Wolf PA: Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med 2006;166:106-111.
10. Kurl S, Laukkanen JA, Niskanen L, Laaksonen D, Sivenius J, Nyyssonen K, Salonen JT: Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 2006;37:806-811.
11. Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, Katayama S, Saito Y, Ito H, Ohashi Y, Akanuma Y, Yamada N: Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 2005;28:1463-1471.
12. Simons LA, Simons J, Friedlander Y, McCallum J: Does a diagnosis of the metabolic syndrome provide additional prediction of cardiovascular disease and total mortality in the elderly? The Dubbo Study. Med J Aust 2007;186:400-403.
13. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G: The Metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005;28:385-390.
14. Galassi A, Reynolds K, He J: Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119:812-819.
15. Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304.
16. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2007. http://www.ohri.ca/programs/ clinical_epidemiology/oxford.htm (accessed July 15, 2007).
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
18. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
19. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Group: Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000;283:2008-2012.
20. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
21. Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, Mannarino E: Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 2004;43:1817-1822.
22. Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs. Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005;165:2644-2650.
23. Maggi S, Noale M, Gallina P, Bianchi D, Marzari C, Limongi F, Crepaldi G, ILSA Working Group: Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci 2006;61:505-510.
24. Liu J, Grundy SM, Wang W, Smith SC, Vega GL, Wu Z, Zeng Z, Wang W, Zhao D: Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J 2007;153:552-558.
25. Iso H, Sato S, Kitamura A, Imano H, Kiyama M, Yamagishi K, Cui R, Tanigawa T, Shimamoto T: Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 2007;38:1744-1751.
26. Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Rahman M, Arima H, Tsuryuya K, Iida M, Kiyohara Y: Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study. Stroke 2007;38:2063-2069.